Determination of the androgen receptor status of circulating tumour cells in metastatic breast cancer patients

BACKGROUND: The prognostic relevance of circulating tumour cells (CTCs) in metastatic breast cancer (MBC) patients has been confirmed by several clinical trials. However, predictive blood-based biomarkers for stratification of patients for targeted therapy are still lacking. The DETECT studies explo...

Descripción completa

Detalles Bibliográficos
Autores principales: Krawczyk, Natalia, Neubacher, Melissa, Meier-Stiegen, Franziska, Neubauer, Hans, Niederacher, Dieter, Ruckhäberle, Eugen, Mohrmann, Svjetlana, Hoffmann, Jürgen, Kaleta, Thomas, Banys-Paluchowski, Malgorzata, Reinecke, Petra, Esposito, Irene, Janni, Wolfgang, Fehm, Tanja
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2019
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6852746/
https://www.ncbi.nlm.nih.gov/pubmed/31718606
http://dx.doi.org/10.1186/s12885-019-6323-8

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6852746/
https://www.ncbi.nlm.nih.gov/pubmed/31718606
http://dx.doi.org/10.1186/s12885-019-6323-8

Ejemplares similares